74 related articles for article (PubMed ID: 17472243)
1. Surface topography and ultrastructure correlation between human breast infiltrating ductal carcinoma of non special type and coexisting human breast infiltrating ductal carcinoma of non special type with in situ comedo carcinoma.
Voloudakis GE; Baltatzis GE; Stefanou D; Agnantis NJ; Voloudakis-Baltatzis IE
J BUON; 2003; 8(2):151-6. PubMed ID: 17472243
[TBL] [Abstract][Full Text] [Related]
2. Biochemical and ultrastructural correlations of calreticulin and thioredoxin expression in breast mucinous carcinoma and infiltrating ductal carcinoma non-special type.
Baltatzis GE; Gaitanarou H; Arnogianaki N; Misitzis J; Voloudakis-Baltatzis IE
Ultrastruct Pathol; 2011 Feb; 35(1):7-13. PubMed ID: 20929309
[TBL] [Abstract][Full Text] [Related]
3. Surface topography and ultrastructural changes of mucinous carcinoma breast cells.
Voloudakis GE; Baltatzis GE; Agnantis NJ; Arnogianaki N; Misitzis J; Voloudakis-Baltatzis I
Ultrastruct Pathol; 2007; 31(4):263-71. PubMed ID: 17786827
[TBL] [Abstract][Full Text] [Related]
4. Spectral morphometric characterization of breast carcinoma cells.
Barshack I; Kopolovic J; Malik Z; Rothmann C
Br J Cancer; 1999 Mar; 79(9-10):1613-9. PubMed ID: 10188915
[TBL] [Abstract][Full Text] [Related]
5. Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression.
Poller DN; Silverstein MJ; Galea M; Locker AP; Elston CW; Blamey RW; Ellis IO
Mod Pathol; 1994 Feb; 7(2):257-62. PubMed ID: 7911998
[TBL] [Abstract][Full Text] [Related]
6. Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological features.
Palacios J; Benito N; Pizarro A; Suárez A; Espada J; Cano A; Gamallo C
Am J Pathol; 1995 Mar; 146(3):605-12. PubMed ID: 7534041
[TBL] [Abstract][Full Text] [Related]
7. Ultrastructure of the periductal area of comedo carcinoma in situ of the breast.
Tang P; Teichberg S; Roberts B; Hajdu SI
Ann Clin Lab Sci; 2001 Jul; 31(3):284-90. PubMed ID: 11508833
[TBL] [Abstract][Full Text] [Related]
8. Extra-long projections of the cell surface in nonspecial-type ductal carcinoma with vascular invasion under the scanning electron microscope.
Voloudakis GE; Baltatzis GE; Kandylis K; Arnogiannakis N; Misitzis J; Voloudakis-Baltatzis I
Ultrastruct Pathol; 2010 Apr; 34(2):73-7. PubMed ID: 20192703
[TBL] [Abstract][Full Text] [Related]
9. Differences in quantitative nuclear features between ductal carcinoma in situ (DCIS) with and without accompanying invasive carcinoma in the surrounding breast.
Susnik B; Worth A; Palcic B; Poulin N; LeRiche J
Anal Cell Pathol; 1995 Jan; 8(1):39-52. PubMed ID: 7734410
[TBL] [Abstract][Full Text] [Related]
10. p53 mutations are confined to the comedo type ductal carcinoma in situ of the breast. Immunohistochemical and sequencing data.
O'Malley FP; Vnencak-Jones CL; Dupont WD; Parl F; Manning S; Page DL
Lab Invest; 1994 Jul; 71(1):67-72. PubMed ID: 8041120
[TBL] [Abstract][Full Text] [Related]
11. Infiltrating ductal carcinoma breast with central necrosis closely mimicking ductal carcinoma in situ (comedo type): a case series.
Pervez S; Khan H
J Med Case Rep; 2007 Sep; 1():83. PubMed ID: 17825107
[TBL] [Abstract][Full Text] [Related]
12. [Histological classification of malignant breast neoplasms. Recent concepts].
Hébert H; Gentile-Fradet A
J Gynecol Obstet Biol Reprod (Paris); 1975; 4 SUPPL 2():21-40. PubMed ID: 172553
[TBL] [Abstract][Full Text] [Related]
13. The risk of occult invasive breast cancer after excisional biopsy showing in-situ ductal carcinoma of comedo pattern.
Hardman PD; Worth A; Lee U; Baird RM
Can J Surg; 1989 Jan; 32(1):56-60. PubMed ID: 2535949
[TBL] [Abstract][Full Text] [Related]
14. BigH3 protein expression as a marker for breast cancer.
Calaf GM; Echiburú-Chau C; Zhao YL; Hei TK
Int J Mol Med; 2008 May; 21(5):561-8. PubMed ID: 18425347
[TBL] [Abstract][Full Text] [Related]
15. Lobular intraepithelial neoplasia [lobular carcinoma in situ] with comedo-type necrosis: A clinicopathologic study of 18 cases.
Fadare O; Dadmanesh F; Alvarado-Cabrero I; Snyder R; Stephen Mitchell J; Tot T; Wang SA; Ghofrani M; Eusebi V; Martel M; Tavassoli FA
Am J Surg Pathol; 2006 Nov; 30(11):1445-53. PubMed ID: 17063087
[TBL] [Abstract][Full Text] [Related]
16. Genetic abnormalities in mammary ductal intraepithelial neoplasia-flat type ("clinging ductal carcinoma in situ"): a simulator of normal mammary epithelium.
Moinfar F; Man YG; Bratthauer GL; Ratschek M; Tavassoli FA
Cancer; 2000 May; 88(9):2072-81. PubMed ID: 10813719
[TBL] [Abstract][Full Text] [Related]
17. Microvessel density, proliferating activity, p53 and bcl-2 expression in in situ ductal carcinoma of the breast.
Zolota V; Gerokosta A; Melachrinou M; Kominea A; Aletra C; Scopa CD
Anticancer Res; 1999; 19(4B):3269-74. PubMed ID: 10652623
[TBL] [Abstract][Full Text] [Related]
18. Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer.
Tong AW; Papayoti MH; Netto G; Armstrong DT; Ordonez G; Lawson JM; Stone MJ
Clin Cancer Res; 2001 Mar; 7(3):691-703. PubMed ID: 11297266
[TBL] [Abstract][Full Text] [Related]
19. Neuroendocrine carcinomas of the breast.
Rovera F; Masciocchi P; Coglitore A; La Rosa S; Dionigi G; Marelli M; Boni L; Dionigi R
Int J Surg; 2008; 6 Suppl 1():S113-5. PubMed ID: 19167937
[TBL] [Abstract][Full Text] [Related]
20. Pathologic variables predictive of breast events in patients with ductal carcinoma in situ.
Fisher ER; Land SR; Saad RS; Fisher B; Wickerham DL; Wang M; Costantino JP; Wolmark N
Am J Clin Pathol; 2007 Jul; 128(1):86-91. PubMed ID: 17580274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
